|
Diabetes, Vol 46, Issue 4 671-681, Copyright © 1997 by American Diabetes Association
Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells
PA Craven, RK Studer, J Felder, S Phillips and FR DeRubertis
Department of Medicine, University of Pittsburgh, Pennsylvania, USA. pcraven@unixs.cis.pitt.edu
Culture of mesangial cells (MCs) in 5.6 vs. 30.0 mmol/l glucose for 3 weeks
induced a sustained increase in protein kinase C (PKC) activity,
transforming growth factor (TGF)-beta1 mRNA, bioactive TGF-beta, and
collagen synthesis. Nitric oxide (NO), generated exogenously by the NO
donor S-nitroso-N-acetyl, D,L-penicillamine (SNAP) or endogenously after
the exposure of MC to interleukin-1beta (IL-1beta), suppressed bioactive
TGF-beta in MCs cultured in 5.6 or 30.0 mmol/l glucose and suppressed or
abolished increases in TGF-beta1 mRNA and collagen synthesis induced by
high concentrations of glucose or phorbol 12,13-dibutyrate without altering
values obtained with normal glucose concentrations. SNAP had a transient
suppressive effect on PKC activity, which may explain at least in part some
of the actions of SNAP. The selective inhibitor of PKC, bisindolylmaleimide
(GFX), mimicked NO action. The ability of SNAP and IL-1beta to suppress
TGF-beta and collagen synthesis was not mediated by cGMP, since the cGMP
analog, 8-Br-PET-cGMP, did not mimic NO action and an antagonist of
cGMP-dependent protein kinase, Rp-8-pCPT-cGMPs, did not prevent the
inhibitory actions of SNAP. N-omega-L-arginine methyl ester (NMMA)
increased TGF-beta in glomerular capillary endothelial cells (GCECs) and
stimulated collagen synthesis by MC in a co-culture with GCECs. Captopril
inhibited TGF-beta and collagen synthesis and increased cGMP in co-cultures
of GCECs and MCs. These effects of captopril were abolished by NMMA,
implying mediation by NO. Thus, endogenous NO produced by GCECs may
modulate TGF-beta production by both GCECs and MCs and act to suppress
matrix protein synthesis by MCs.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M.G. Ferrini, I. Kovanecz, S. Sanchez, D. Vernet, H.H. Davila, J. Rajfer, and N.F. Gonzalez-Cadavid
Long-Term Continuous Treatment with Sildenafil Ameliorates Aging-Related Erectile Dysfunction and the Underlying Corporal Fibrosis in the Rat
Biol Reprod,
May 1, 2007;
76(5):
915 - 923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chao, H.-J. Li, Y.-Y. Yao, B. Shen, L. Gao, G. Bledsoe, and L. Chao
Kinin Infusion Prevents Renal Inflammation, Apoptosis, and Fibrosis via Inhibition of Oxidative Stress and Mitogen-Activated Protein Kinase Activity
Hypertension,
March 1, 2007;
49(3):
490 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. O'Riordan, N. Mendelev, S. Patschan, D. Patschan, J. Eskander, L. Cohen-Gould, P. Chander, and M. S. Goligorsky
Chronic NOS inhibition actuates endothelial-mesenchymal transformation
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H285 - H294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Alpay, G. M. Saed, and M. P. Diamond
Female Infertility and Free Radicals: Potential Role in Adhesions and Endometriosis
Reproductive Sciences,
September 1, 2006;
13(6):
390 - 398.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-F. Xia, G. Bledsoe, L. Chao, and J. Chao
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats
Am J Physiol Renal Physiol,
September 1, 2005;
289(3):
F622 - F631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. R. DeRubertis, P. A. Craven, M. F. Melhem, and E. M. Salah
Attenuation of Renal Injury in db/db Mice Overexpressing Superoxide Dismutase: Evidence for Reduced Superoxide-Nitric Oxide Interaction
Diabetes,
March 1, 2004;
53(3):
762 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Sanders
Salt Intake, Endothelial Cell Signaling, and Progression of Kidney Disease
Hypertension,
February 1, 2004;
43(2):
142 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-Z. Ying and P. W. Sanders
The interrelationship between TGF-{beta}1 and nitric oxide is altered in salt-sensitive hypertension
Am J Physiol Renal Physiol,
November 1, 2003;
285(5):
F902 - F908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bledsoe, L. Chao, and J. Chao
Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol,
October 1, 2003;
285(4):
H1479 - H1488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pfeilschifter, W. Eberhardt, and A. Huwiler
Nitric Oxide and Mechanisms of Redox Signaling
J. Am. Soc. Nephrol.,
August 1, 2003;
14(90003):
S237 - 240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Meek, S. K. Cooney, S. D. Flynn, R. F. Chouinard, M. H. Poczatek, J. E. Murphy-Ullrich, and K. R. Tuttle
Amino acids induce indicators of response to injury in glomerular mesangial cells
Am J Physiol Renal Physiol,
July 1, 2003;
285(1):
F79 - F86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Komers and S. Anderson
Paradoxes of nitric oxide in the diabetic kidney
Am J Physiol Renal Physiol,
June 1, 2003;
284(6):
F1121 - F1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wang, S. Shiva, M. H. Poczatek, V. Darley-Usmar, and J. E. Murphy-Ullrich
Nitric Oxide and cGMP-dependent Protein Kinase Regulation of Glucose-mediated Thrombospondin 1-dependent Transforming Growth Factor-beta Activation in Mesangial Cells
J. Biol. Chem.,
March 15, 2002;
277(12):
9880 - 9888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Craven, M. F. Melhem, S. L. Phillips, and F. R. DeRubertis
Overexpression of Cu2+/Zn2+ Superoxide Dismutase Protects Against Early Diabetic Glomerular Injury in Transgenic Mice
Diabetes,
September 1, 2001;
50(9):
2114 - 2125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Raij
Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction
Hypertension,
February 1, 2001;
37(2):
767 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Poczatek, C. Hugo, V. Darley-Usmar, and J. E. Murphy-Ullrich
Glucose Stimulation of Transforming Growth Factor-{beta} Bioactivity in Mesangial Cells Is Mediated by Thrombospondin-1
Am. J. Pathol.,
October 1, 2000;
157(4):
1353 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Gavin, D. A. Spector, H. Wagner, E. C. Breen, and P. D. Wagner
Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise
J Appl Physiol,
April 1, 2000;
88(4):
1192 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lagadec, S. Raynal, B. Lieubeau, N. Onier, L. Arnould, V. Saint-Giorgio, D. A. Lawrence, and J.-F. Jeannin
Evidence for Control of Nitric Oxide Synthesis by Intracellular Transforming Growth Factor-ß1 in Tumor Cells : Implications for Tumor Development
Am. J. Pathol.,
June 1, 1999;
154(6):
1867 - 1876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Cohen, F. N. Ziyadeh, G. T. Lautenslager, J. A. Cohen, and C. W. Shearman
Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells
Am J Physiol Renal Physiol,
May 1, 1999;
276(5):
F684 - F690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Raij
Nitric Oxide in Hypertension: Relationship With Renal Injury and Left Ventricular Hypertrophy
Hypertension,
January 1, 1998;
31(1):
189 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|